Author

R. Saddawi-Konefka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

A. Sharabi· 2 shared J. S. Gutkind· 2 shared V. H. Wu· 2 shared A. A. Molinolo· 1 shared A. B. Simon· 1 shared A. O'Farrell· 1 shared B. A. Fox· 1 shared B. S. Yung· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Sharabi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivFeb 1, 2022

Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC

R. Saddawi-Konefka, A. O'Farrell, F. Faraji…·J. S. Gutkind

This study shows that lymphatic-preserving treatment sequences enhance cDC1-dependent antitumor immunity in HNSCC by avoiding lymphablation, which compromises ICI response.

DOI 10.1038/s41467-022-31941-w

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedJan 27, 2022

Microneedle-mediated intratumoral delivery of anti-CTLA-4 promotes cDC1-dependent eradication of oral squamous cell carcinoma with limited irAEs

M. Gilardi, R. Saddawi-Konefka, V. H. Wu…·J. S. Gutkind

This study demonstrates that microneedle-mediated local delivery of anti-CTLA-4 antibody reduces immune-related adverse events while effectively treating oral squamous cell carcinoma.

DOI 10.1158/1535-7163.mct-21-0234

mouseexperimental assay

𝕏 PostBluesky